Literature DB >> 11501884

Clinical, pathological and immunological aspects of periodontal disease.

D F Kinane1, D F Lappin.   

Abstract

The inflammatory and immune responses during the development and progression of periodontitis are reviewed. Susceptibility to periodontitis may be related to whether plasma cells predominate in the tissues of an individual, or a site, in response to the microbial insult from dental plaque. The tendency for an individual or site to form an extensive plasma cell infiltrate may indicate an inability to defend against periodontopathogenic bacteria and thus a predisposition to periodontitis. Selected pertinent areas of current interest in cellular and humoral immunology are considered within the periodontal context. These topical issues include (a) homing of immune and inflammatory cells to target tissues; (b) the local proliferation and synthetic activity of immune and inflammatory cells; (c) the cytokine profile of the inflammatory and immune cells; and (d) the immunoglobulin subclasses of locally produced antibodies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11501884     DOI: 10.1080/000163501750266747

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  22 in total

1.  The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction.

Authors:  G P Garlet; C R B Cardoso; A P Campanelli; B R Ferreira; M J Avila-Campos; F Q Cunha; J S Silva
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Effect of periodontal therapy on salivary interleukin-12 levels in chronic periodontitis.

Authors:  Anamika Sharma; B P Khattak; S Naagtilak; Ganesh Singh; Tanveer Bano
Journal:  J Clin Diagn Res       Date:  2014-10-20

3.  Comparative analysis of the blood flow values of patients with type 2 diabetes mellitus presenting with chronic periodontitis, patients with chronic periodontitis only and healthy individuals.

Authors:  H Develioglu; H Özdemir; V Bostanci
Journal:  West Indian Med J       Date:  2014-06-10       Impact factor: 0.171

4.  Effect of neutrophil apoptosis on monocytic cytokine response to Porphyromonas gingivalis lipopolysaccharide.

Authors:  Ezel Berker; Alpdogan Kantarci; Hatice Hasturk; Thomas E Van Dyke
Journal:  J Periodontol       Date:  2005-06       Impact factor: 6.993

5.  Levels of parotid and submandibular/sublingual salivary immunoglobulin A in response to experimental gingivitis in humans.

Authors:  R Seemann; S J Hägewald; V Sztankay; J Drews; M Bizhang; A Kage
Journal:  Clin Oral Investig       Date:  2004-08-14       Impact factor: 3.573

6.  Neutrophils rescue gingival epithelial cells from bacterial-induced apoptosis.

Authors:  Johnah C Galicia; Manjunatha R Benakanakere; Panagiota G Stathopoulou; Denis F Kinane
Journal:  J Leukoc Biol       Date:  2009-04-23       Impact factor: 4.962

7.  Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients.

Authors:  Ketil Moen; Johan G Brun; Tor Magne Madland; Turid Tynning; Roland Jonsson
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

8.  Immunization enhances inflammation and tissue destruction in response to Porphyromonas gingivalis.

Authors:  Cataldo W Leone; Haneen Bokhadhoor; David Kuo; Tesfahun Desta; Julia Yang; Michelle F Siqueira; Salomon Amar; Dana T Graves
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

9.  Hyper-responsive phenotype in localized aggressive periodontitis.

Authors:  L Shaddox; J Wiedey; E Bimstein; I Magnuson; M Clare-Salzler; I Aukhil; S M Wallet
Journal:  J Dent Res       Date:  2009-12-30       Impact factor: 6.116

10.  Blocking proinflammatory cytokine release modulates peripheral blood mononuclear cell response to Porphyromonas gingivalis.

Authors:  Ezel Berker; Alpdogan Kantarci; Hatice Hasturk; Thomas E Van Dyke
Journal:  J Periodontol       Date:  2012-11-23       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.